These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9148535)

  • 1. [Activated protein C resistance in patients with venous leg ulcer].
    Munkvad S; Jørgensen M
    Ugeskr Laeger; 1997 Mar; 159(14):2100-2. PubMed ID: 9148535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration.
    Munkvad S; Jørgensen M
    Br J Dermatol; 1996 Feb; 134(2):296-8. PubMed ID: 8746345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration.
    Falanga V; Bontempo FA; Eaglstein WH
    Arch Dermatol; 1990 Sep; 126(9):1195-7. PubMed ID: 2144413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.
    Lindahl TL; Lundahl TH; Nilsson L; Andersson CA
    Thromb Haemost; 1999 Jan; 81(1):18-21. PubMed ID: 10348713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers?
    Peus D; Heit JA; Pittelkow MR
    J Am Acad Dermatol; 1997 Apr; 36(4):616-20. PubMed ID: 9092749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease.
    Bazzan M; Tamponi G; Vaccarino A; Montaruli B; Aluffi E; Schinco P; Pannocchia A; Borchiellini A; Rabbia C; Pileri A
    Haematologica; 1997; 82(4):420-2. PubMed ID: 9299854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to activated protein C: role in venous and arterial thrombosis.
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.
    Hillarp A; Zöller B; Svensson PJ; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):990-2. PubMed ID: 9308741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
    Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
    Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.